Screener
Merck & Co. MRK Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Merck & Co.’s reported figures.
Based on trailing twelve months.
The source filing: Merck & Co.’s 10-Q, filed May 4, 2026. Open the filing →
- Filed
- May 4, 2026, 4:10 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0001628280-26-029802
FAQ
- What is Merck & Co.'s return on equity?
- Merck & Co. (MRK) reported return on equity of 19% in Q1 2026.
- How has Merck & Co.'s return on equity changed year-over-year?
- Merck & Co.'s return on equity decreased by 51.7% year-over-year, from 39.3% to 19%.
- What is the long-term trend for Merck & Co.'s return on equity?
- Over 3 years (2021 to 2025), Merck & Co.'s return on equity has grown at a -3.5% compound annual growth rate (CAGR), from 41.1% to 36.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Merck & Co.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude